Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.
Farkouh ME, Greenberg JD, Jeger RV, Ramanathan K, Verheugt FW, Chesebro JH, Kirshner H, Hochman JS, Lay CL, Ruland S, Mellein B, Matchaba PT, Fuster V, Abramson SB.
Ann Rheum Dis. 2007 Jun;66(6):764-70. Epub 2007 Apr 5.PMID: 17412741 [PubMed - indexed for MEDLINE]Related articles